MAPT and Alzheimer disease: PET imaging with radioligand Fluorine 18-labeled (18F) AV-1451 biomarker exhibited excessive uptake in assessing tau and NFTs deposits in the precuneus and temporal gyrus regions of the brain in cognitively impaired AD patients.